Scientists from Duke-NUS Medical School (Duke-NUS) in Singapore and their collaborators have come up with new methods to...
The multi-target research and development partnership will focus on severe skin diseases • &nbs...
In a world-first, researchers at the Royal Adelaide Hospital (RAH) and the University of Adelaide in Australia are seeki...
The third edition of the "Asia Pacific Forum on Precision Cancer Treatment" concluded today with a dynamic exchange of i...
Devmanyu Singh, Integrated Health Solution Lead at Roche, takes center stage at the Asia Pacific Forum on Precis...
National Heart Centre Singapore (NHCS) has partnered with US-based Medera’s Novoheart to create the world’s ...
Cervical cancer presents a paradoxical situation. It is one of the cancers that can be prevented if detected early, but ...
The Austrlian government is unlocking the power and potential of personalised medicine with $66 million for genomics res...
Jiahui Health and IASO Biotechnology have announced a deepening of their strategic collaboration to jointly build a ...
In recent years, fluorescence-based lateral flow immunoassay (LFI) has gained popularity as a diagnostic tool for viral ...
MedChem Australia, a first-of-its-kind national initiative connecting three of the nation’s top medicinal chemistr...
US-based biotech firm Moderna, Inc. has announced the launch of the mRNA Platform Incubator Network, a pioneering initia...
Wound management is essential to ensure a speedy and safe recovery, and tissue adhesive patches are an attractive option...
SG Austria (“Austrianova”), a leading provider of cell biological products and services, on 31st Oct an...
US-based startup AnHeart Therapeutics has entered into an exclusive license agreement with Nippon Kayaku to market ...
A local study led by the Agency for Science, Technology and Research (A*STAR) discovered that by inhibiting the function...
LianBio, a biotechnology startup dedicated to bringing innovative medicines to patients in China and other major Asian m...
Australian researchers have been awarded $AU1 million ($687,000) from the US Food and Drug Administration (FDA) to devel...
